← Browse by Condition
Medical Condition
primary open angle glaucoma poag
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for primary open angle glaucoma poag sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07462000
Recruiting
Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract
Enrollment
40 pts
Location
Poland
Sponsor
Military Institute od Medicine...
NCT06921317 Phase 1, Phase 2
Recruiting
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
Enrollment
12 pts
Location
China
Sponsor
IVIEW Therapeutics Inc.
NCT06792422 Phase 4
Recruiting
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
Enrollment
126 pts
Location
Denmark
Sponsor
Glostrup University Hospital, ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology